Allogenetics

Seed
allogenetics.de Biotech & Healthcare Hanover, Germany
Total Funding $4.4M
Latest Round $4.4M Seed
Last Announced Sep 9, 2026
Investors 3 Backers
Decision Makers 1 Verified

About Allogenetics

Allogenetics provides a unique solution to the problem of organ rejection following transplantation.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Hanover, Germany
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website allogenetics.de
Domain Registered Date Dec 7, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $4,427,760 · Seed

    biospace.com

  2. Milestone

    Website domain registered

    allogenetics.de

Investors & Backers

3
Carma Fund
Life Science Valley Wachstumsfond
NBank Capital

Funding History

1 Round
Seed · Sep 9, 2026
$4,427,760 biospace.com

Founders & Leadership

5

Constanca Figueiredo

Founder

Work email & phone locked Unlock →

Jeroen Rovers

Chief Medical Officer

Work email & phone locked Unlock →

Oliver Ernst

CEO and Managing Director

Work email & phone locked Unlock →

Phillipp Langrehr

Founder

Work email & phone locked Unlock →

Rainer Blasczyk

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts